Walder Wyss advised SkyCell AG on all legal and tax aspects of this transaction. SkyCell AG closed its $116 million Series D financing round which embarked...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised SkyCell AG on all legal and tax aspects on this transaction. Swiss based SkyCell AG has completed a USD 57 million equity financing...
You must be a Standard 1 Year member to access this content.
